Pharmaceutical packaging machinery industry analysis
Global market trends, growth and forecast to 2020.
Research and Markets has announced the addition of the "Pharmaceutical Packaging Machinery Industry Analysis — Global Market Trends, Growth & Forecast to 2020" report to their offering.
The Pharmaceutical Packaging Machinery Market to be worth $5.3 billion in 2014 and is poised to reach $7.8 billion by 2020. The market is growing at an estimated CAGR of 6.7% in the next 5 years.
This report analyses the global markets for pharmaceutical packaging machinery across all the given segments. It presents historical market data for 2012, 2013 and 2014, and forecasts for 2020. The report focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report provides comprehensive market analysis across four major geographies such as North America, Europe, Asia Pacific and other parts of the world.
A special focus has been made on countries such as US, Canada, UK, Germany, Spain, France, Italy, Australia, Japan, China, India, Brazil, Saudi Arabia, UAE and South Africa. The market data is gathered from extensive primary research and secondary research. The market sizing analysis includes both top-down and bottom-up approaches for data validation and measures.
Report Highlights:
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.